The Effect of Glucagon-like-Peptide-1 Receptor Agonists on Diabetic Retinopathy Progression, Central Subfield Thickness, and Response to Intravitreal Injections.

Other notable variables that differed between groups but did not reach statistical significance were: tobacco use (37.1% vs. 19.4%, respectively; p = 0.11, Pearson’s chi-square), insulin use (82.9% vs. 64.5%, respectively; p = 0.09, Pearson’s chi-square), SGLT2 inhibitor use (42.9% vs. 25.8%, respectively; p = 0.15, Pearson’s chi-square), vitrectomy at baseline (20.0% vs. 6.5%, respectively; p = 0.10, Pearson’s chi-square), and presence of IRF (62.9% vs. 80.6%, respectively; p = 0.11, Pearson’s chi-square).

also in 111,027 other papers